CASP1 and acute lymphoblastic leukemia: As for malignancies of lymphoid origin, CASP1 and NLRP3 showed significantly higher expression in glucocorticoid-resistant primary leukemia cells from patients diagnosed with acute lymphoblastic (ALL) compared to cells sensitive to glucocorticoids [218].